Giant cell glioblastoma multiforme (GCGBM) is an uncommon subtype within the spectrum of glioblastoma multiforme (GBM) tumors. Neurofibromatosis type 1 (NF1) has an increased risk of developing neoplasms that generally are of a benign nature. We report a rare case of an exophytic GCGBM in a 43-year-old woman with NF1. The tumor located in the right frontal region was removed totally and the patient underwent radiotherapy with 60 Gy and chemotherapy with temozolomide. 
Introduction
Giant cell glioblastoma multiforme (GCGBM) is a rare subtype of glioblastoma multiforme (GBM) tumors, occurring generally in the cerebral hemispheres. GCGBM predominantly occurs in younger patients and is more likely to allow for total resection.
Consequently, compared with GBM, this tumor is associated with a better prognosis (1) . Its magnetic resonance imaging (MRI) features, tumor size, and localization are similar to GBM except for its clear demarcations (2) .
Few GCGBM cases with NF1 have been documented, such as GCGBM with bilateral cerebellopontine angle location in a patient with NF1 (3), GCGBM associated with NF1 in an 8-year-old patient (4) , and exophytic GCGBM of the medulla oblongata (5). GBM is the most malignant primary cerebral tumor and accounts for 50% of all gliomas in adults. GCGBM is a variant of GBM and accounts for 5% of all GBMs and 1% of primary brain tumors (9) . Although GCGBM is associated with better prognosis and long-term survival of the patients, some GCGBM cases with fatal outcome and short survival time have also been reported (10) . Our patient presented in this report ameliorated after a combination of surgery and radiochemotherapy.
Case Presentation
To our knowledge, few reports of GCGBM cases are associated with NF1 patients. GCGBM with bilateral cerebellopontine angle location in a patient with NF1, GCGBM associated with NF1 in an 8-year-old patient, and exophytic GCGBM of the medulla oblongata have been reported (3) (4) (5) . We report an exophytic GCGBM in the right frontal region in a patient with NF1.
It is important to differentiate GCGBM from the other high-grade tumors, subependymal giant cell astrocytoma, pleomorphic xanthoastrocytoma and metastasis, because it may have a better prognosis and longer-time survival. 
